Volume 15, Number 7—July 2009
Research
Clusters of Multidrug-Resistant Mycobacterium tuberculosis Cases, Europe
Table 1
Number of diagnosed MDR TB cases reported in 24 European countries and number and proportion of genotyped MDR TB strains, as reported to the MDR TB surveillance project, by year, January 2003 through June 2007*
| Country | No. cases reported |
No. genotyped strains reported |
||||||
|---|---|---|---|---|---|---|---|---|
| 2003 | 2004 | 2005 | 2006 and 2007 | Total | All | With data (% total cases) | ||
| Belgium† (EU) | 9 | 14 | 7 | 1 | 31 | 15 | 15 (48) | |
| Croatia | 2 | 1 | 2 | – | 5 | 5 | 5 (100) | |
| Cyprus (EU) | 2 | 0 | 1 | – | 3 | – | – | |
| Czech Republic (EU) | 15 | 13 | 4 | 6 | 38 | 11 | 5 (13) | |
| Denmark (EU) | 0 | 0 | 5 | – | 5 | 4 | 4 (80) | |
| Estonia (EU) | 96 | 80 | 72 | – | 248 | 228 | 228 (92) | |
| Finland (EU) | 3 | 0 | 2 | 2 | 7 | 7 | 7 (100) | |
| France (EU) | 53 | 53 | 46 | – | 152 | 63 | 63 (41) | |
| Germany (EU) | – | – | 101 | – | 101 | 17 | 16 (16) | |
| Ireland (EU) | 1 | 2 | 3 | 2 | 8 | 3 | 3 (38) | |
| Israel | 18 | 15 | 12 | – | 45 | 39 | 39 (87) | |
| Italy (EU) | 45 | 18 | 17 | 3 | 83 | 25 | 25 (30) | |
| Latvia (EU) | 188 | 208 | 160 | 156 | 712 | – | – | |
| Lithuania (EU) | – | 318 | 338 | – | 656 | 56 | 56 (9) | |
| Macedonia, FYR | 4 | 1 | 6 | 4 | 15 | – | – | |
| Netherlands (EU) | 17 | 10 | 7 | – | 34 | 44 | 34 (100) | |
| Norway (EU) | 2 | 4 | 3 | 2 | 11 | 7 | 3 (27) | |
| Poland (EU) | – | – | 1 | 16 | 17 | – | – | |
| Romania (EU) | – | 25 | 25 | – | 50 | – | – | |
| Slovenia (EU) | 1 | 0 | 1 | 1 | 3 | 2 | 2 (67) | |
| Spain (EU) | – | 28 | 22 | – | 50 | 50 | 50 (100) | |
| Sweden (EU) | 7 | 7 | 4 | 3 | 21 | 21 | 18 (86) | |
| Switzerland | 9 | 9 | 3 | 4 | 25 | 25 | 20 (80) | |
| United Kingdom (EU) |
68 |
52 |
54 |
– |
174 |
50 |
– |
|
| Total | 540 | 858 | 896 | 200 | 2,494 | 672 | 593 (39) | |
*MDR TB, multidrug-resistant tuberculosis; EU, European Union; –, not available; FYR, Former Yugoslav Republic of Macedonia.
†Includes only cases detected at the start of treatment.


